All In Biotech

Drug Trial Radar · NCT07625670

Clinical Study to Evaluate Remineralization Using an in Situ Model.

Clinical Study to Evaluate Enamel Remineralization Using Three Dentifrices in an in Situ Model.

Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitationPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Enrolling by invitation

Enrollment

30

Planned (sponsor's estimate)

Start

Sep 3, 2026

Primary completion

Oct 2026

Study completion Oct 2026

Sponsor

Lead sponsor
Colgate PalmoliveIndustry
Sponsor type
Industry
Collaborators
Federal University of Paraíba
First posted
Jun 4, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a phase III clinical trial that aims to evaluate the enamel remineralization efficacy of three dentifrices on artificial caries lesions using an in situ model. The study involves 30 healthy volunteers, aged 18 to 70, who will participate in a randomized, triple-blind, three-period crossover design. Researchers will compare a 750 ppm MFP dentifrice against a 1450 ppm MFP positive control and a fluoride-free negative control to measure variations in mineral gain. Participants will wear a removable intraoral appliance containing human enamel blocks for three 14-day experimental phases. A 7-day washout period using will be implemented before and between each treatment phase.

Conditions

  • Remineralization
  • Enamel Lesions
  • Enamel Subsurface Lesion

Interventions

  • Fluoride toothpaste containing 750 ppm MFP in a Dical baseDrug

    Subjects will brush using a fluoride toothpaste containing 750 ppm MFP in a Dical base and a soft bristle toothbrush for 14 days

  • Fluoride toothpaste containing 1450 ppm MFP in a Dical baseDrug

    Subjects will brush using a fluoride toothpaste containing 1450 ppm MFP in a Dical base and a soft bristle toothbrush for 14 days

  • Fluoride-free toothpaste in a Dical baseDrug

    Subjects will brush using a fluoride-free toothpaste in a Dical base and a soft bristle toothbrush for 14 days

  • ToothbrushDevice

    A commercially available adult soft bristle toothbrush

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in integrated mineral loss (Δz)Time frame: 9 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Federal University of Paraíba

    João Pessoa, Paraíba, Brazil

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.